NEDD4L and colorectal cancer: 14-3-3σ reportedly recruited S448-phosphorylation of NEDD4L to mediate ubiquitination and downregulation of hypoxia-inducible factor-1a (HIF-1a), thereby inhibiting colorectal cancer angiogenesis and enhancing sensitivity to bevacizumab (Liu et al., 2023).